Dr. Kasim Kazbay, MD

Dr. Kazbay practices at Mount Sinai South Nassau in Oceanside, New York, part of Mount Sinai Health System.

Dr. Kazbay's NPI, 1265747489, was assigned on August 12, 2010. Dr. Kazbay holds New York license 269455.

Dr. Kazbay's primary practice is Mount Sinai South Nassau, at One Healthy Way, Oceanside, NY 11572 in Nassau County. The practice phone is (516) 632-3000. Dr. Kazbay also practices at South Nassau Communities Hospital, 1 Healthy Way, Oceanside, NY 11572.

Dr. Kazbay's primary practice is Mount Sinai South Nassau in Oceanside, New York, part of Mount Sinai Health System. Dr. Kazbay is also affiliated with The Mount Sinai Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Kazbay to 2 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kazbay practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Kazbay's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Kazbay's licenses on file in 2 states: New York and West Virginia.

CMS data shows 1,209 Medicare services from Dr. Kazbay across 12 procedure codes in 2024, for 542 Medicare patients. Medicare paid $103,976 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 542 Medicare patients who saw Dr. Kazbay in 2024. The largest group is 75 to 84, with 203 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kazbay's median patient age at 66, with 47% women.

In 2021, Dr. Kazbay wrote 26 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $266 in total drug cost. In 2020, CMS named 174 claims across 5 drugs.

Dr. Kazbay accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 138 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Kazbay, more than 83% of the clinicians it reports for that procedure.

CMS Open Payments shows 54 general payments to Dr. Kazbay from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $142.